BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 34788626)

  • 1. Genomic and molecular features distinguish young adult cancer from later-onset cancer.
    Lee W; Wang Z; Saffern M; Jun T; Huang KL
    Cell Rep; 2021 Nov; 37(7):110005. PubMed ID: 34788626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pan-Cancer Comparative and Integrative Analyses of Driver Alterations Using Japanese and International Genomic Databases.
    Horie S; Saito Y; Kogure Y; Mizuno K; Ito Y; Tabata M; Kanai T; Murakami K; Koya J; Kataoka K
    Cancer Discov; 2024 May; 14(5):786-803. PubMed ID: 38276885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Immune Landscape of Cancer.
    Thorsson V; Gibbs DL; Brown SD; Wolf D; Bortone DS; Ou Yang TH; Porta-Pardo E; Gao GF; Plaisier CL; Eddy JA; Ziv E; Culhane AC; Paull EO; Sivakumar IKA; Gentles AJ; Malhotra R; Farshidfar F; Colaprico A; Parker JS; Mose LE; Vo NS; Liu J; Liu Y; Rader J; Dhankani V; Reynolds SM; Bowlby R; Califano A; Cherniack AD; Anastassiou D; Bedognetti D; Mokrab Y; Newman AM; Rao A; Chen K; Krasnitz A; Hu H; Malta TM; Noushmehr H; Pedamallu CS; Bullman S; Ojesina AI; Lamb A; Zhou W; Shen H; Choueiri TK; Weinstein JN; Guinney J; Saltz J; Holt RA; Rabkin CS; ; Lazar AJ; Serody JS; Demicco EG; Disis ML; Vincent BG; Shmulevich I
    Immunity; 2018 Apr; 48(4):812-830.e14. PubMed ID: 29628290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Features of Cancers Exhibiting Exceptional Responses to Treatment.
    Wheeler DA; Takebe N; Hinoue T; Hoadley KA; Cardenas MF; Hamilton AM; Laird PW; Wang L; Johnson A; Dewal N; Miller V; Piñeyro D; Castro de Moura M; Esteller M; Shen H; Zenklusen JC; Tarnuzzer R; McShane LM; Tricoli JV; Williams PM; Lubensky I; O'Sullivan-Coyne G; Kohn EC; Little RF; White J; Malik S; Harris L; Weil C; Chen AP; Karlovich C; Rodgers B; Shankar L; Jacobs P; Nolan T; Hu J; Muzny DM; Doddapaneni H; Korchina V; Gastier-Foster J; Bowen J; Leraas K; Edmondson EF; Doroshow JH; Conley BA; Ivy SP; Staudt LM
    Cancer Cell; 2021 Jan; 39(1):38-53.e7. PubMed ID: 33217343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer.
    Chen M; Chen R; Jin Y; Li J; Hu X; Zhang J; Fujimoto J; Hubert SM; Gay CM; Zhu B; Tian Y; McGranahan N; Lee WC; George J; Hu X; Chen Y; Wu M; Behrens C; Chow CW; Pham HHN; Fukuoka J; Wu J; Parra ER; Little LD; Gumbs C; Song X; Wu CJ; Diao L; Wang Q; Cardnell R; Zhang J; Wang J; Le X; Gibbons DL; Heymach JV; Jack Lee J; William WN; Cheng C; Glisson B; Wistuba I; Andrew Futreal P; Thomas RK; Reuben A; Byers LA; Zhang J
    Nat Commun; 2021 Nov; 12(1):6655. PubMed ID: 34789716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer.
    Rogic A; Pant I; Grumolato L; Fernandez-Rodriguez R; Edwards A; Das S; Sun A; Yao S; Qiao R; Jaffer S; Sachidanandam R; Akturk G; Karlic R; Skobe M; Aaronson SA
    Nat Commun; 2021 Nov; 12(1):6889. PubMed ID: 34824220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reprogramming NK cells and macrophages via combined antibody and cytokine therapy primes tumors for elimination by checkpoint blockade.
    Wang C; Cui A; Bukenya M; Aung A; Pradhan D; Whittaker CA; Agarwal Y; Thomas A; Liang S; Amlashi P; Suh H; Spranger S; Hacohen N; Irvine DJ
    Cell Rep; 2021 Nov; 37(8):110021. PubMed ID: 34818534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A renal cell carcinoma tumorgraft platform to advance precision medicine.
    Elias R; Tcheuyap VT; Kaushik AK; Singla N; Gao M; Reig Torras O; Christie A; Mulgaonkar A; Woolford L; Stevens C; Kettimuthu KP; Pavia-Jimenez A; Boroughs LK; Joyce A; Dakanali M; Notgrass H; Margulis V; Cadeddu JA; Pedrosa I; Williams NS; Sun X; DeBerardinis RJ; Öz OK; Zhong H; Seshagiri S; Modrusan Z; Cantarel BL; Kapur P; Brugarolas J
    Cell Rep; 2021 Nov; 37(8):110055. PubMed ID: 34818533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell analysis of diverse immune phenotypes in malignant pleural effusion.
    Huang ZY; Shao MM; Zhang JC; Yi FS; Du J; Zhou Q; Wu FY; Li S; Li W; Huang XZ; Zhai K; Shi HZ
    Nat Commun; 2021 Nov; 12(1):6690. PubMed ID: 34795282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic features of soft tissue tumours in adolescents and young adults.
    Tam YB; Low K; Ps H; Chadha M; Burns J; Wilding CP; Arthur A; Chen TW; Thway K; Sadanandam A; Jones RL; Huang PH
    Commun Med (Lond); 2024 May; 4(1):93. PubMed ID: 38762630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic landscape of diploid and aneuploid microsatellite stable early onset colorectal cancer.
    Zhou Y; Chen X; Chen J; Kendrick CD; Ramanathan RK; Graham RP; Kossick KF; Boardman LA; Barrett MT
    Sci Rep; 2024 Apr; 14(1):9368. PubMed ID: 38654044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering age-specific molecular features in cervical cancer and constructing an angio-immune prognostic model.
    Zhao X; Fan X; Lin X; Guo B; Yu Y
    Medicine (Baltimore); 2024 Apr; 103(15):e37717. PubMed ID: 38608077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients.
    Al-Danakh A; Safi M; Jian Y; Yang L; Zhu X; Chen Q; Yang K; Wang S; Zhang J; Yang D
    Front Immunol; 2024; 15():1348189. PubMed ID: 38590525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing Annual Cancer Incidence in Patients Age 20-49 Years: A Real-Data Study.
    Ribelles N; Pascual J; Galvez-Carvajal L; Ruiz-Medina S; Garcia-Corbacho J; Benitez JC; Dominguez-Recio ME; Torres E; Oliva L; Zalabardo M; Rueda A; Alba E
    JCO Glob Oncol; 2024 Mar; 10():e2300363. PubMed ID: 38513186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic analysis reveals a tissue-specific loss of identity during ageing and cancer.
    Dos Santos GA; Chatsirisupachai K; Avelar RA; de Magalhães JP
    BMC Genomics; 2023 Oct; 24(1):644. PubMed ID: 37884865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics of early-onset colorectal cancer.
    Marx O; Mankarious M; Yochum G
    World J Biol Chem; 2023 Mar; 14(2):13-27. PubMed ID: 37034132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priorities to Promote Participant Engagement in the Participant Engagement and Cancer Genome Sequencing (PE-CGS) Network.
    Schuster AL; Crossnohere NL; Bachini M; Blair CK; Carpten JD; Claus EB; Colditz GA; Ding L; Drake BF; Fields RC; Janeway KA; Kwan BM; Lenz HJ; Ma Q; Mishra SI; Paskett ED; Rebbeck TR; Ricker C; Stern MC; Sussman AL; Tiner JC; Trent JM; Verhaak RG; Wagle N; Willman C; Bridges JF;
    Cancer Epidemiol Biomarkers Prev; 2023 Apr; 32(4):487-495. PubMed ID: 36791345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic disparities between cancers in adolescent and young adults and in older adults.
    Wang X; Langevin AM; Houghton PJ; Zheng S
    Nat Commun; 2022 Nov; 13(1):7223. PubMed ID: 36433963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rethinking Patient Engagement in Cancer Research.
    Schuster ALR; Hampel H; Paskett ED; Bridges JFP
    Patient; 2023 Mar; 16(2):89-93. PubMed ID: 36301439
    [No Abstract]   [Full Text] [Related]  

  • 20. How Genetics and Genomics Advances Are Rewriting Pediatric Cancer Research and Clinical Care.
    Cipri S; Abenavoli L; Boccuto L; Del Baldo G; Mastronuzzi A
    Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.